SABRIL ® (vigabatrin) for oral solution. Approved Use. SABRIL (vigabatrin) is a prescription medicine used with other treatments in adults and children 2 years of age and older with refractory complex partial seizures (CPS) who have not responded well enough to several other treatments and if the possible benefits outweigh the risk of vision loss.

SABRIL (vigabatrin) is a prescription medicine used with other treatments in adults and children 2 years of age and older with refractory complex partial seizures (CPS) who have not responded well enough to several other treatments and if the possible benefits outweigh the …

SABRIL (vigabatrin) is a prescription medicine used with other treatments in adults and children 2 years of age and older with refractory complex partial seizures (CPS) who have not responded well enough to several other treatments and if the possible benefits outweigh the …

SABRIL (vigabatrin) is a prescription medicine used with other treatments in adults and children 2 years of age and older with refractory complex partial seizures (CPS) who have not responded well enough to several other treatments and if the possible benefits outweigh the …

SABRIL ® (vigabatrin) for oral solution. Approved Use. SABRIL (vigabatrin) is a prescription medicine used with other treatments in adults and children 2 years of age and older with refractory complex partial seizures (CPS) who have not responded well enough to several other treatments and if the possible benefits outweigh the risk of vision loss.

Feb 16, 2017 · SABRIL (vigabatrin) is a prescription medicine used in babies, 1 month to 2 years old, with infantile spasms (IS), if the possible benefits outweigh the possible risk of vision loss.

SABRIL (vigabatrin) is indicated as monotherapy for pediatric patients, 1 month to 2 years of age, with infantile spasms (IS) for whom the potential benefits outweigh the potential risk of vision loss.

(“Informational Support”) is available for eligible Sabril (vigabatrin) patients only. Informational Support should not replace conversations between patients and their health care providers or their office staff, is not insurance or a guarantee of coverage or …

Oct 24, 2019 · treated for infantile spasms (IS) with vigabatrin.” Prescriber Action Counsel patients about the risks and benefits of Sabril, including the reports of IME. Tell your patients and/or caregivers to contact a healthcare professional immediately to report any change in the neurological status or developmental progress of the patient.

SABRIL (vigabatrin) is indicated as adjunctive therapy for patients 2 years of age and older with refractory complex partial seizures (CPS) who have inadequately responded to several alternative treatments and for whom the potential benefits outweigh the risk of vision loss.